References
- 1Pearson ML, Bridges CB, Harper SA. Influenza vaccination of health-care personnel. CDC, Mortality and Morbidity Weekly Report. 2006; 55: 1–16. DOI: 10.4161/hv.28154
- 2Control CfD, Prevention. Vaccine preventable deaths and the Global Immunization Vision and Strategy, 2006–2015. Morbidity and Mortality Weekly Report. 2006; 55: 511. PMID: 16691182.
- 3Khazaei S, Rezaeian S, Razani M, et al. Adverse events following immunization (AEFI) in children under 7 years of age during 2014 in Hamedan Province, Iran. International Journal of Pediatrics. 2016; 4: 1697–703.
http://eprints.lums.ac.ir/id/eprint/650 . - 4Ayatallahi A, Rajaeefard A, Namakin K. Epidemiologic study of infant mortality and its risk factors in Birjand health houses in rural areas are covered. Journal of Babol University of Medical Sciences. 2013; 10: 9–15.
- 5Agergaard J, Nante E, Poulstrup G, et al. Diphtheria–tetanus–pertussis vaccine administered simultaneously with measles vaccine is associated with increased morbidity and poor growth in girls. A randomised trial from Guinea-Bissau. Vaccine. 2011; 29: 487–500. DOI: 10.1016/j.vaccine.2010.10.071
- 6World Health Organization. WHO vaccine-preventable diseases: Monitoring system: 2009 global summary. Geneva: World Health Organization; 2009.
- 7Uprety P, Poudel A. Earthquake risk perception among citizens in Kathmandu, Nepal. Australasian Journal of Disaster and Trauma Studies. 2012; 2012: 3–10.
https://www.massey.ac.nz/~trauma/issues/2012-1/AJDTS_2012-1_Uprety.pdf . - 8Watson JC, LeBaron CW, Hutchins SS, et al. General Recommendations on Immunization: Recommendations of the Advisory Committee on Immunization Practices (ACIP). Morbidity and Mortality Weekly Report: Recommendations and Reports. 1994; 1–38.
- 9Sharafi R, Mortazavi J, Heidarzadeh A. Comparison of complications of pentavalent and DTP vaccination in infants aged 2–6 months in Anzali, Iran. Iranian Journal of Neonatology. 2016; 7: 1–6.
http://eprints.mums.ac.ir/id/eprint/2055 . - 10Kliegman R, Stanton BM, Geme JS. Nelson tratado de pediatría. Brasil: Elsevier; 2014.
- 11Sreedhar S, Antony A, Poulose N. Study on the effectiveness and impact of pentavalent vaccination program in India and other south Asian countries. Human Vaccines & Immunotherapeutics. 2014; 10: 2062–5. DOI: 10.4161/hv.28785
- 12Oliveira CR, Baltimore RS. Complications of Vaccination With Bacille Calmette-Guérin. Clinical Pediatrics. 2014; 53: 914–6. DOI: 10.1177/0009922814533414
- 13Hatami H, Arshi S, Sarikhani R. The relationship between side effects of the Pentavalent vaccine and mother’s education level in areas under the auspices of Shahid Beheshti University of Medical Sciences in 2015. Journal of Health in the Field. 2016; 3.
- 14Karami M, Ameri P, Bathaei J, et al. Adverse events following immunization with pentavalent vaccine: Experiences of newly introduced vaccine in Iran. BMC Immunology. 2017; 18: 42. DOI: 10.1186/s12865-017-0226-8
- 15Ayatollahi J, Zare A. Short Course Adverse Events following DTP vaccination in Yazd during 2005. Iran J Pediatr. 2006; 16: 332–4.
- 16Mansoor O, Pillans P. Vaccine adverse events reported in New Zealand 1990–5. The New Zealand Medical Journal. 1997; 110: 270–2. PMID: 9269289.
- 17Al-Jadiryinin. Childhood Immunization. J Lecture. 2012; 21: 311–5.
- 18Barkin RM, Pichichero ME. Diphtheria-pertussis-tetanus vaccine: Reactogenicity of commercial products. Pediatrics. 1979; 63: 256–60.
http://www.pediatrics.org . - 19Key S. Whooping Cough: A Study in Immunization. The American Journal of the Medical Sciences. 1933; 185: 586. DOI: 10.1001/jama.1933.02740040007003
- 20Malik A. Pentavalent Vaccine and Adverse Events Following Immunization—Untangling the Misinterpretations. The Indian Journal of Pediatrics. 2014; 81: 1353–7. DOI: 10.1007/s12098-013-1322-2
- 21Eskola J, Käyhty H, Gordon LK, et al. Simultaneous administration of Haemophilus influenzae type b capsular polysaccharide-diphtheria toxoid conjugate vaccine with routine diphtheria-tetanus-pertussis and inactivated poliovirus vaccinations of childhood. The Pediatric Infectious Disease Journal. 1988; 7: 480–4. DOI: 10.1097/00006454-198807000-00006
- 22Guerra FA, Blatter MM, Greenberg DP, et al. Safety and immunogenicity of a pentavalent vaccine compared with separate administration of licensed equivalent vaccines in US infants and toddlers and persistence of antibodies before a preschool booster dose: A randomized, clinical trial. Pediatrics. 2009; 123: 301–12. DOI: 10.1542/peds.2007-3317
- 23Ferreccio C, Clemens J, Avendano A, et al. The clinical and immunologic response of Chilean infants to Haemophilus influenzae type b polysaccharide-tetanus protein conjugate vaccine coadministered in the same syringe with diphtheria-tetanus toxoids-pertussis vaccine at two, four and six months of age. The Pediatric Infectious Disease Journal. 1991; 10: 764–71. DOI: 10.1097/00006454-199110000-00009
- 24Folb PI, Bernatowska E, Chen R, et al. A global perspective on vaccine safety and public health: The Global Advisory Committee on Vaccine Safety. American Journal of Public Health. 2004; 94: 1926–31. DOI: 10.2105/AJPH.94.11.1926
- 25Sharma HJ, Yadav S, Lalwani SK, et al. Immunogenicity and safety of an indigenously manufactured reconstituted pentavalent (DTwP-HBV+Hib) vaccine in comparison with a foreign competitor following primary and booster immunization in Indian children. Human Vaccines. 2011; 7: 451–7. DOI: 10.4161/hv.7.4.14208
- 26Faingezicht I, Avila-Aguerro ML, Cervantes Y, et al. Primary and booster vaccination with DTPw-HB/Hib pentavalent vaccine in Costa Rican children who had received a birth dose of hepatitis B vaccine. Revista Panamericana de Salud Pública. 2002; 12: 247–57. DOI: 10.1590/S1020-49892002001000005
- 27Cunha MP, Dórea JG, Marques RC, et al. Vaccine adverse events reported during the first ten years (1998–2008) after introduction in the state of Rondonia, Brazil. BioMed Research International. 2013; 85: 6. DOI: 10.1155/2013/853083
- 28Raeeisi a MM, Karimi F, Saberinejad F. Assessment of Diphteria, Tetanus and Pertusis Vaccine-associated Complications in Infants under 7 Years Old in Shahrekord in 2010–2012. Journal of Ilam University of Medical Sciences. 2014; 22(10): 321.
- 29Parisaee Z, Esteghamati A, Ghashghaei KZ, et al. Adverse Effects of DPT Vaccine in Children below 7 Years of Age in Rural and Urban Areas of Kohgiloye and Boyerahmad Province In 2006. Armaghane Danesh Bimonthly Journal. 2008; 13: 105–14.
- 30Ayatollahi J, Zare A. Evaluation of the side effects of triple vaccine in Yazd in 2005. Iranian Journal of Pediatrics. 2006; 16: 332–6.
http://hdl.handle.net/1807/58309 . - 31Nabavi M, Jandaghi J, Ghorbani R, Khaleghi Hashemian M, et al. The incidence of complications of vaccination in infants and infants of Semnan, Iran. Koomesh. 2010; 11: 245–54.